INNOVATION PHARMACEUTICALS INC. Basic Shares Outstanding (Weighted Average)
INNOVATION PHARMACEUTICALS INC. reported Basic Shares Outstanding (Weighted Average) of 396.12 million shares for the 9-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2021-05-13
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2021-03-31 was 495.57M shares, a 67.05% increase year-over-year.
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2020-12-31 was 355.28M shares, a 65.88% increase year-over-year.
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2020-09-30 was 337.49M shares, a 64.10% increase year-over-year.
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for the quarter ending 2020-03-31 was 296.66M shares.
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2019 was 178.23M shares, a 23.33% increase from fiscal 2018.
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2018 was 144.51M shares, a 13.53% increase from fiscal 2017.
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2017 was 127.29M shares, a 6.15% increase from fiscal 2016.
- INNOVATION PHARMACEUTICALS INC. weighted average number of shares outstanding, basic for fiscal 2016 was 119.91M shares, a 4.19% increase from fiscal 2015.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2021-03-31 | 495.57M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | 425.43M shares derived: average of 2 quarters · filed 2021-05-13 | 396.12M shares 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 355.28M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-22 | 346.39M shares 10-Q · filed 2021-02-22 | ||
| 2020-09-30 | 337.49M shares 10-Q · filed 2020-11-16 | |||
| 2020-03-31 | 296.66M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | 255.42M shares derived: average of 2 quarters · filed 2021-05-13 | 238.84M shares 10-Q · filed 2021-05-13 | |
| 2019-12-31 | 214.18M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-22 | 209.93M shares 10-Q · filed 2021-02-22 | ||
| 2019-09-30 | 205.67M shares 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | 178.23M shares 10-K · filed 2019-09-30 | |||
| 2018-06-30 | 144.51M shares 10-K · filed 2019-09-30 | |||
| 2017-06-30 | 127.29M shares 10-K · filed 2018-09-11 | |||
| 2016-06-30 | 119.91M shares 10-K · filed 2017-09-11 | |||
| 2015-09-30 | 115.09M shares 10-Q · filed 2015-11-09 | |||
| 2015-06-30 | 115.09M shares 10-K · filed 2017-09-11 | |||
| 2014-09-30 | 105.04M shares 10-Q · filed 2015-11-09 | |||
| 2014-06-30 | 105.04M shares 10-K · filed 2016-09-13 | |||
| 2013-06-30 | 94.98M shares 10-Q · filed 2015-11-09 | |||
| 2012-06-30 | 90.16M shares 10-K · filed 2014-09-15 |